Replies to post #128401 on Biotech Values

[genisi]

There's an ongoing patent litigation on Teva’s Azilect - there's a Paragraph IV challenge and a 30 month stay on approval till Nov 2013 (or a district court decision).

[jq1234]

FDA committee unanimously rejects expanded indication for rasagiline (Azilect) in Parkinson's, 17-0.